Summary of Key Information:
Reporting Period (Quarter/Year): Not Applicable
Nature of Filing / Announcement: Outcome of Board Meeting - Preferential Allotment of Equity Shares under Regulation 30 of SEBI LODR
Audit Opinion:
Not Specified
Key Financial Highlights:
Not Specified
Standalone Results:
Not Specified
Consolidated Results:
Not Specified
Segment-wise Performance:
Not Specified
Corporate Actions:
The Board of Directors approved the allotment of 24,39,750 fully paid-up equity shares of face value of ₹10 each at an issue price of ₹293 per equity share (including a premium of ₹283 per share).
Total amount raised: ₹71,48,46,750 (Seventy-One Crore Forty-Eight Lakhs Forty-Six Thousand Seven Hundred and Fifty Only)
Allotment was made to two non-promoter investors:
- AGI Group Holdings Inc.: 22,77,100 equity shares
- Monoflus Pte. Ltd.: 1,62,650 equity shares
The allotment was made pursuant to:
- Special Resolution passed by Members at Extra-Ordinary General Meeting held on August 10, 2026
- In-principle approval from BSE Limited (LOD/PREF/DA/FIP/877/2026-27 dated October 1, 2026)
- In-principle approval from National Stock Exchange of India Limited (NSE/LIST/56391 dated October 1, 2026)
- Receipt of full consideration from allottees
The shares rank pari passu with existing equity shares of the Company. The allotted shares will be subject to lock-in periods as specified under Chapter V of SEBI (ICDR) Regulations, 2018.
Post-allotment shareholding pattern changes:
- AGI Group Holdings Inc.: Increased from 0 shares (0%) to 22,77,100 shares (1.11%)
- Monoflus Pte. Ltd.: Increased from 71,70,000 shares (3.59%) to 73,32,650 shares (3.58%)
The Company will apply to Stock Exchanges for listing and trading approval of the allotted shares.
Other Significant Information:
Not Specified